Get quick answers to your questions about the article from our AI researcher chatbot
{'id': 'https://openalex.org/W1964391488', 'doi': 'https://doi.org/10.7326/0003-4819-117-4-338', 'title': 'Retinoid Therapy for Acute Promyelocytic Leukemia: A Coming of Age for the Differentiation Therapy of Malignancy', 'display_name': 'Retinoid Therapy for Acute Promyelocytic Leukemia: A Coming of Age for the Differentiation Therapy of Malignancy', 'publication_year': 1992, 'publication_date': '1992-08-15', 'ids': {'openalex': 'https://openalex.org/W1964391488', 'doi': 'https://doi.org/10.7326/0003-4819-117-4-338', 'mag': '1964391488', 'pmid': 'https://pubmed.ncbi.nlm.nih.gov/1637030'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://doi.org/10.7326/0003-4819-117-4-338', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S119722071', 'display_name': 'Annals of Internal Medicine', 'issn_l': '0003-4819', 'issn': ['0003-4819', '1539-3704'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310316812', 'host_organization_name': 'American College of Physicians', 'host_organization_lineage': ['https://openalex.org/P4310316812'], 'host_organization_lineage_names': ['American College of Physicians'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'letter', 'type_crossref': 'journal-article', 'indexed_in': ['crossref', 'pubmed'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5044470461', 'display_name': 'David Parkinson', 'orcid': 'https://orcid.org/0000-0002-7464-2351'}, 'institutions': [{'id': 'https://openalex.org/I4210140884', 'display_name': 'National Cancer Institute', 'ror': 'https://ror.org/040gcmg81', 'country_code': 'US', 'type': 'government', 'lineage': ['https://openalex.org/I1299022934', 'https://openalex.org/I1299303238', 'https://openalex.org/I4210140884']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'David R. Parkinson', 'raw_affiliation_strings': ['Cancer Therapy Evaluation Program National Cancer Institute Bethesda, MD 20892'], 'affiliations': [{'raw_affiliation_string': 'Cancer Therapy Evaluation Program National Cancer Institute Bethesda, MD 20892', 'institution_ids': ['https://openalex.org/I4210140884']}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5046943976', 'display_name': 'Malcolm A. Smith', 'orcid': 'https://orcid.org/0000-0001-9880-9876'}, 'institutions': [{'id': 'https://openalex.org/I4210140884', 'display_name': 'National Cancer Institute', 'ror': 'https://ror.org/040gcmg81', 'country_code': 'US', 'type': 'government', 'lineage': ['https://openalex.org/I1299022934', 'https://openalex.org/I1299303238', 'https://openalex.org/I4210140884']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Malcolm A. Smith', 'raw_affiliation_strings': ['Cancer Therapy Evaluation Program National Cancer Institute Bethesda, MD 20892'], 'affiliations': [{'raw_affiliation_string': 'Cancer Therapy Evaluation Program National Cancer Institute Bethesda, MD 20892', 'institution_ids': ['https://openalex.org/I4210140884']}]}], 'institution_assertions': [], 'countries_distinct_count': 1, 'institutions_distinct_count': 1, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': None, 'has_fulltext': True, 'fulltext_origin': 'ngrams', 'cited_by_count': 9, 'citation_normalized_percentile': {'value': 0.576786, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 76, 'max': 78}, 'biblio': {'volume': '117', 'issue': '4', 'first_page': '338', 'last_page': '340'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T11559', 'display_name': 'Retinoids in leukemia and cellular processes', 'score': 1.0, 'subfield': {'id': 'https://openalex.org/subfields/1312', 'display_name': 'Molecular Biology'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, 'topics': [{'id': 'https://openalex.org/T11559', 'display_name': 'Retinoids in leukemia and cellular processes', 'score': 1.0, 'subfield': {'id': 'https://openalex.org/subfields/1312', 'display_name': 'Molecular Biology'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, {'id': 'https://openalex.org/T10309', 'display_name': 'Acute Myeloid Leukemia Research', 'score': 0.9927, 'subfield': {'id': 'https://openalex.org/subfields/2720', 'display_name': 'Hematology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/differentiation-therapy', 'display_name': 'Differentiation Therapy', 'score': 0.7154865}, {'id': 'https://openalex.org/keywords/promyelocytic-leukemia-protein', 'display_name': 'Promyelocytic leukemia protein', 'score': 0.49603733}, {'id': 'https://openalex.org/keywords/tretinoin', 'display_name': 'Tretinoin', 'score': 0.46221465}], 'concepts': [{'id': 'https://openalex.org/C2776601000', 'wikidata': 'https://www.wikidata.org/wiki/Q612108', 'display_name': 'Acute promyelocytic leukemia', 'level': 4, 'score': 0.96404254}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.8094286}, {'id': 'https://openalex.org/C2779982571', 'wikidata': 'https://www.wikidata.org/wiki/Q25098780', 'display_name': 'Differentiation therapy', 'level': 5, 'score': 0.7154865}, {'id': 'https://openalex.org/C2781121885', 'wikidata': 'https://www.wikidata.org/wiki/Q425517', 'display_name': 'Retinoic acid', 'level': 3, 'score': 0.6478106}, {'id': 'https://openalex.org/C2778461978', 'wikidata': 'https://www.wikidata.org/wiki/Q29496', 'display_name': 'Leukemia', 'level': 2, 'score': 0.5474199}, {'id': 'https://openalex.org/C2779399171', 'wikidata': 'https://www.wikidata.org/wiki/Q1483951', 'display_name': 'Malignancy', 'level': 2, 'score': 0.5468398}, {'id': 'https://openalex.org/C502942594', 'wikidata': 'https://www.wikidata.org/wiki/Q3421914', 'display_name': 'Cancer research', 'level': 1, 'score': 0.49855113}, {'id': 'https://openalex.org/C111441629', 'wikidata': 'https://www.wikidata.org/wiki/Q18030615', 'display_name': 'Promyelocytic leukemia protein', 'level': 5, 'score': 0.49603733}, {'id': 'https://openalex.org/C2779963572', 'wikidata': 'https://www.wikidata.org/wiki/Q29417', 'display_name': 'Tretinoin', 'level': 4, 'score': 0.46221465}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.4475407}, {'id': 'https://openalex.org/C143998085', 'wikidata': 'https://www.wikidata.org/wiki/Q162555', 'display_name': 'Oncology', 'level': 1, 'score': 0.417108}, {'id': 'https://openalex.org/C121608353', 'wikidata': 'https://www.wikidata.org/wiki/Q12078', 'display_name': 'Cancer', 'level': 2, 'score': 0.41218007}, {'id': 'https://openalex.org/C86803240', 'wikidata': 'https://www.wikidata.org/wiki/Q420', 'display_name': 'Biology', 'level': 0, 'score': 0.095930964}, {'id': 'https://openalex.org/C54355233', 'wikidata': 'https://www.wikidata.org/wiki/Q7162', 'display_name': 'Genetics', 'level': 1, 'score': 0.08228493}, {'id': 'https://openalex.org/C81885089', 'wikidata': 'https://www.wikidata.org/wiki/Q189082', 'display_name': 'Cell culture', 'level': 2, 'score': 0.07644829}], 'mesh': [{'descriptor_ui': 'D015473', 'descriptor_name': 'Leukemia, Promyelocytic, Acute', 'qualifier_ui': 'Q000188', 'qualifier_name': 'drug therapy', 'is_major_topic': True}, {'descriptor_ui': 'D009369', 'descriptor_name': 'Neoplasms', 'qualifier_ui': 'Q000188', 'qualifier_name': 'drug therapy', 'is_major_topic': True}, {'descriptor_ui': 'D012176', 'descriptor_name': 'Retinoids', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': True}, {'descriptor_ui': 'D002454', 'descriptor_name': 'Cell Differentiation', 'qualifier_ui': 'Q000187', 'qualifier_name': 'drug effects', 'is_major_topic': False}, {'descriptor_ui': 'D002454', 'descriptor_name': 'Cell Differentiation', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D006801', 'descriptor_name': 'Humans', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D015473', 'descriptor_name': 'Leukemia, Promyelocytic, Acute', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D009369', 'descriptor_name': 'Neoplasms', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D012176', 'descriptor_name': 'Retinoids', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D014212', 'descriptor_name': 'Tretinoin', 'qualifier_ui': 'Q000009', 'qualifier_name': 'adverse effects', 'is_major_topic': False}, {'descriptor_ui': 'D014212', 'descriptor_name': 'Tretinoin', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}], 'locations_count': 2, 'locations': [{'is_oa': False, 'landing_page_url': 'https://doi.org/10.7326/0003-4819-117-4-338', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S119722071', 'display_name': 'Annals of Internal Medicine', 'issn_l': '0003-4819', 'issn': ['0003-4819', '1539-3704'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310316812', 'host_organization_name': 'American College of Physicians', 'host_organization_lineage': ['https://openalex.org/P4310316812'], 'host_organization_lineage_names': ['American College of Physicians'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, {'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/1637030', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'id': 'https://metadata.un.org/sdg/3', 'score': 0.8, 'display_name': 'Good health and well-being'}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 19, 'referenced_works': ['https://openalex.org/W1539454494', 'https://openalex.org/W1542461367', 'https://openalex.org/W1554600230', 'https://openalex.org/W1923263537', 'https://openalex.org/W1965388358', 'https://openalex.org/W1985639811', 'https://openalex.org/W2005576285', 'https://openalex.org/W2046657068', 'https://openalex.org/W2063083122', 'https://openalex.org/W2116097769', 'https://openalex.org/W2118099369', 'https://openalex.org/W2141083396', 'https://openalex.org/W2150930737', 'https://openalex.org/W2168731357', 'https://openalex.org/W2177441413', 'https://openalex.org/W2222964685', 'https://openalex.org/W2327237185', 'https://openalex.org/W2407345634', 'https://openalex.org/W4246713397'], 'related_works': ['https://openalex.org/W4388452973', 'https://openalex.org/W3126933831', 'https://openalex.org/W2802103649', 'https://openalex.org/W2136199362', 'https://openalex.org/W2089470325', 'https://openalex.org/W2032816080', 'https://openalex.org/W2018374421', 'https://openalex.org/W2010216204', 'https://openalex.org/W1973178021', 'https://openalex.org/W1963646528'], 'abstract_inverted_index': {'Editorials15': [0], 'August': [1, 677, 692], '1992Retinoid': [2], 'Therapy': [3, 15, 631], 'for': [4, 12, 29, 40, 110, 120, 234, 317, 415, 541, 565], 'Acute': [5], 'Promyelocytic': [6], 'Leukemia:': [7], 'A': [8, 661], 'Coming': [9], 'of': [10, 16, 60, 86, 98, 103, 107, 114, 117, 136, 139, 141, 145, 150, 174, 176, 210, 217, 249, 319, 336, 358, 382, 437, 454, 488, 503, 517, 545, 570, 585, 650, 659, 668], 'Age': [11], 'the': [13, 95, 115, 137, 142, 177, 215, 273, 334, 518, 546, 571, 613, 648, 666], 'Differentiation': [14, 247], 'MalignancyDavid': [17], 'R.': [18, 26, 622], 'Parkinson,': [19, 27, 623], 'MD,': [20, 24, 38, 628], 'Malcolm': [21, 35, 625], 'A.': [22, 36, 626], 'Smith,': [23, 37, 627], 'PhDDavid': [25], 'MDSearch': [28], 'more': [30, 41], 'papers': [31, 42], 'by': [32, 43, 184, 272, 460], 'this': [33, 44, 58, 87], 'author,': [34], 'PhDSearch': [39], 'authorAuthor,': [45], 'Article,': [46, 617], 'and': [47, 63, 106, 132, 315, 331, 345, 355, 417, 434, 480, 491, 559, 583, 618, 654, 662, 674], 'Disclosure': [48, 619], 'Informationhttps://doi.org/10.7326/0003-4819-117-4-338': [49], 'SectionsAboutPDF': [50], 'ToolsAdd': [51], 'to': [52, 93], 'favoritesDownload': [53], 'CitationsTrack': [54], 'CitationsPermissions': [55], 'ShareFacebookTwitterLinkedInRedditEmail': [56], 'ExcerptIn': [57], 'issue': [59], 'Annals,': [61], 'Frankel': [62], 'colleagues': [64], '(1)': [65], 'describe': [66], 'a': [67, 99, 134, 148, 231, 281, 302, 339, 407, 461], 'syndrome': [68, 89, 160], 'that': [69], 'developed': [70], 'in': [71, 124, 161, 198, 214, 276, 294, 321, 333, 363, 386, 410, 420, 441, 481, 647, 656, 665], 'patients': [72, 125, 364, 421], 'with': [73, 79, 126, 253, 301, 365, 402, 422, 483, 506], 'acute': [74, 127, 162, 218, 235, 250, 277, 296, 423, 538], 'promyelocytic': [75, 128, 163, 179, 219, 236, 251, 278, 297, 424], 'leukemia': [76, 129, 180, 252, 279, 298, 521], 'during': [77], 'treatment': [78, 216, 401, 584], 'all-trans': [80, 211, 360, 383, 403, 438, 455], 'retinoic': [81, 118, 158, 185, 212, 228, 361, 384, 404, 439, 456, 504], 'acid': [82, 119, 159, 213, 229, 362, 385, 405, 440, 457, 478, 505, 533, 558, 652], '(1).': [83], 'The': [84, 157, 267], 'description': [85], 'dramatic': [88], 'provides': [90], 'an': [91], 'opportunity': [92], 'review': [94], 'larger': [96], 'significance': [97], 'remarkable': [100], 'new': [101], 'class': [102], 'drugs,': [104], 'retinoids,': [105], 'differentiation': [108, 143, 175, 232, 487, 516], 'therapy': [109, 144, 233, 248, 540, 564], 'malignancy.The': [111], 'unfolding': [112], 'story': [113], 'use': [116], 'successful': [121], 'remission': [122], 'induction': [123], 'is': [130, 133, 604], 'instructive': [131], 'confirmation': [135], 'coming': [138], 'age': [140], 'malignancy.': [146], 'Long': [147], 'goal': [149], 'cancer': [151, 199, 320, 657], 'therapists,': [152], 'it': [153], 'is...References1.': [154], 'FrankelEardleyLauwersWeissWarrell': [155], 'SAGMR.': [156], 'leukemia.': [164, 220, 237, 425], 'Ann': [165], 'Intern': [166], 'Med.': [167, 260], '1992;117:292-6.': [168], 'LinkGoogle': [169], 'Scholar2.': [170], 'BreitmanSelonicCollins': [171], 'TSS.': [172], 'Induction': [173], 'human': [178, 295, 489, 519], 'cell': [181, 522, 543, 568], 'line': [182, 523], '(HL-60)': [183], 'acid.': [186], 'Proc': [187, 369, 390, 467], 'Natl': [188, 549, 574], 'Acad': [189], 'Sci': [190], 'USA.': [191], '1980;77:2936-40.': [192], 'CrossrefMedlineGoogle': [193, 205, 223, 243, 262, 287, 310, 428, 498, 553, 578, 590, 600], 'Scholar3.': [194], 'SmithParkinsonChesonFriedman': [195], 'MDBM.': [196], 'Retinoids': [197, 330], 'therapy.': [200], 'J': [201, 259, 444, 548, 573, 596], 'Clin': [202, 372, 393, 445, 470, 597], 'Oncol.': [203, 373, 394, 446, 471, 496, 598], '1992;10:839-64.': [204], 'Scholar4.': [206], 'HuangYeChenChaiLuZhoa': [207], 'MYSJJL.': [208], 'Use': [209], 'Blood.': [221, 241, 426], '1988;72:567-72.': [222], 'Scholar5.': [224], 'CastaigneChomienneDanielBalleriniBerger': [225], 'SCMPR.': [226], 'All-trans': [227], 'as': [230], 'I.': [238], 'Clinical': [239], 'results.': [240], '1990;76:1704-9.': [242], 'Scholar6.': [244], 'WarrellFrankelMillerScheinbergItri': [245], 'RSWDL.': [246], 'tretinoin': [254], '(all-trans-retinoic': [255], 'acid).': [256], 'N': [257], 'Engl': [258], '1991;324:1385-93.': [261], 'Scholar7.': [263], 'de': [264], 'TheLavauMarchioChomienneDegosDejean': [265], 'HCACLA.': [266], 'PML-RARα': [268], 'fusion': [269], 'mRNA': [270], 'generated': [271], 't(15;17)': [274, 293], 'translocation': [275, 292], 'encodes': [280], 'functionally': [282], 'altered': [283], 'RAR.': [284], 'Cell.': [285, 308], '1991;66:675-84.': [286], 'Scholar8.': [288], 'KakizukaMillerUmesono': [289], 'AWK.': [290], 'Chromosomal': [291], 'fuses': [299], 'RARα': [300], 'novel': [303], 'putative': [304], 'transcription': [305], 'factor,': [306], 'PML.': [307], '1991;66:663-74.': [309], 'Scholar9.': [311], 'BertramKolonelMeyskens': [312], 'JLF.': [313], 'Rationale': [314], 'strategies': [316], 'chemoprevention': [318], 'humans.': [322], 'Cancer': [323, 342, 525, 550, 575, 630, 635, 675], 'Res.': [324, 526], '1987;47:3012-31.': [325], 'MedlineGoogle': [326, 348, 528], 'Scholar10.': [327], 'GarewalMeyskens': [328], 'HF.': [329], 'carotenoids': [332], 'prevention': [335], 'oral': [337, 359], 'cancer:': [338], 'critical': [340], 'appraisal.': [341], 'Epidemiology,': [343], 'Biomarkers,': [344], 'Prevention.': [346], '1992;1:155-9.': [347], 'Scholar11.': [349], 'ConleyWuEgorinHodgesSinibaldiVan': [350], 'Echo': [351], 'BSMSVD.': [352], 'Phase': [353, 379, 432], 'I': [354, 380, 433], 'pharmacokinetic': [356, 435], 'trial': [357], 'solid': [366, 387], 'tumors': [367, 388], '[Abstract].': [368, 389], 'Am': [370, 391, 468], 'Soc': [371, 392, 469], '1992;11:113.': [374], 'Google': [375, 396, 473], 'Scholar12.': [376], "PitotRubinO'Connell": [377], 'HJM.': [378], 'study': [381], '1992;11:126.': [395], 'Scholar13.': [397], 'MuindiFrankelMiller': [398], 'JSW.': [399], 'Continuous': [400], 'causes': [406], 'progressive': [408], 'reduction': [409], 'plasma': [411], 'drug': [412], 'concentrations:': [413], 'implications': [414], 'relapse': [416], 'retinoid': [418], '"resistance"': [419], '1992;79:299-303.': [427], 'Scholar14.': [429], 'SmithAdamsonBalis': [430], 'MPF.': [431], 'evaluation': [436], 'pediatric': [442], 'patients.': [443], '1992;[In': [447], 'press].': [448], 'CrossrefGoogle': [449], 'Scholar15.': [450], 'FrancisRigasMuindiKrisYoungWarrell': [451], 'PJJMCR.': [452], 'Modulation': [453], '(RA)': [458], 'pharmacokinetics': [459], 'cytochrome': [462], 'P-450': [463], 'enzyme': [464], 'system': [465], 'inhibitor.': [466], '1992;11:108.': [472], 'Scholar16.': [474], 'HassanRees': [475], 'HJ.': [476], 'Retinoic': [477], 'alone': [479], 'combination': [482, 563], 'cytosine': [484], 'arabinoside': [485], 'induces': [486], 'myelomonocytic': [490], 'monoblastic': [492], 'leukaemic': [493], 'cells.': [494], 'Hematol': [495], '1988;6:39-45.': [497], 'Scholar17.': [499], 'BreitmanHe': [500], 'TR.': [501], 'Combinations': [502], 'either': [507], 'sodium': [508], 'butyrate,': [509], 'dimethylsulfoxide,': [510], 'or': [511], 'hexamethylene': [512], 'bisacetamide': [513], 'synergistically': [514], 'induce': [515], 'myeloid': [520], 'HL60.': [524], '1990;50:6268-73.': [527], 'Scholar18.': [529], 'LippmanKavanaghParedes-Espinoza': [530], 'SJM.': [531], '13-Cis-retinoic': [532], 'plus': [534], 'interferon-alpha': [535], '2a:': [536], 'highly': [537], 'systemic': [539], 'squamous': [542, 567], 'carcinoma': [544, 569], 'cervix.': [547], 'Inst.': [551, 576], '1992;84:241-5.': [552], 'Scholar19.': [554], 'LippmanParkinsonItri': [555], 'SDL.': [556], '13-cis-retinoic': [557], 'interferon': [560], 'alpha-2a:': [561], 'effective': [562], 'advanced': [566], 'skin.': [572], '1992;84:235-41.': [577], 'Scholar20.': [579], 'RackowAstiz': [580], 'EM.': [581], 'Pathophysiology': [582], 'septic': [586], 'shock.': [587], 'JAMA.': [588], '1991;266:548-54.': [589], 'Scholar21.': [591], 'SiegelPuri': [592], 'JR.': [593], 'Interleukin-2': [594], 'toxicity.': [595], '1991;9:694-704.': [599], 'Scholar': [601], 'This': [602], 'content': [603], 'PDF': [605, 614, 694], 'only.': [606], 'To': [607], 'continue': [608], 'reading': [609], 'please': [610], 'click': [611], 'on': [612], 'icon.': [615], 'Author,': [616], 'InformationAuthors:': [620], 'David': [621], 'MD;': [624], 'PhDAffiliations:': [629], 'Evaluation': [632], 'Program': [633], 'National': [634], 'Institute': [636], 'Bethesda,': [637], 'MD': [638], '20892': [639], 'PreviousarticleNextarticle': [640], 'Advertisement': [641], 'FiguresReferencesRelatedDetails': [642], 'Metrics': [643], 'Cited': [644], 'byContinuous': [645], 'hemofiltration': [646], 'management': [649], '‘retinoic': [651], 'syndrome’RetinoidsPrefaceRetinoids': [653], 'apoptosis': [655], 'therapyRole': [658], 'Vitamin': [660], 'Its': [663], 'Derivatives': [664], 'Treatment': [667], 'Human': [669], 'CancerReverse': [670], 'Transformation,': [671], 'Genome': [672], 'Exposure,': [673], '15': [676, 691], '1992Volume': [678], '117,': [679], 'Issue': [680, 689], '4Page:': [681], '338-340KeywordsDrug': [682], 'therapyDrugsRetinoic': [683], 'acidRetinoids': [684], 'ePublished:': [685], '1': [686], 'December': [687], '2008': [688], 'Published:': [690], '1992': [693], 'downloadLoading': [695], '...': [696]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W1964391488', 'counts_by_year': [], 'updated_date': '2024-12-11T03:18:47.978577', 'created_date': '2016-06-24'}